Fulvestrant Injection is now available in the United States in the company's ready-to-administer prefilled syringes and is the latest addition to Fresenius Kabi's broad oncology portfolio. The product is the only room temperature stable Fulvestrant Injection currently available in the U.S.

Attachments

  • Original document
  • Permalink

Disclaimer

Fresenius SE & Co. KGaA published this content on 07 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 October 2019 18:26:01 UTC